# FDA Inspection 917366 - BCN Peptides SA - January 16, 2015

Source: https://www.keypedia.com/records/fda_inspections/bcn-peptides-sa/c72b8e8a-a419-4da8-bb5c-6f55b734680f
Source feed: FDA_Inspections

> FDA Inspection 917366 for BCN Peptides SA on January 16, 2015. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 917366
- Company Name: BCN Peptides SA
- Inspection Date: 2015-01-16
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1287710 - 2023-10-09](https://www.keypedia.com/records/fda_inspections/bcn-peptides-sa/cf925bad-fd1e-4902-b135-a58739c7029d)
- [FDA Inspection 1110777 - 2019-10-18](https://www.keypedia.com/records/fda_inspections/bcn-peptides-sa/4088d75c-8be1-444c-9e6c-267c197758d6)
- [FDA Inspection 1112160 - 2019-03-15](https://www.keypedia.com/records/fda_inspections/bcn-peptides-sa/e9376b15-28bf-41c5-9574-806490d1bc08)
- [FDA Inspection 787875 - 2012-04-26](https://www.keypedia.com/records/fda_inspections/bcn-peptides-sa/45604398-e18c-4788-84d0-62f15deeded0)
- [FDA Inspection 659207 - 2010-03-18](https://www.keypedia.com/records/fda_inspections/bcn-peptides-sa/8e2aec93-9ccf-490f-acfd-e0c9720dace2)

Company: https://www.keypedia.com/companies/bcn-peptides-sa/b0fa0b1d-5597-4653-9d34-ae9ab14d2de3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c